Table 2. Characteristics of patients in the meta-analysis.
| Characteristics | Number of patients | Percent of patients |
| Age (means 47.6 years) | 2823 | 92.95%(2823/3037) |
| BMI (means 24.2 kg/m2) | 2823 | 92.95%(2823/3037) |
| Female | 1110 | 37.22%(1110/2982) |
| Genotype1 | 2048 | 72.55%(2048/2823) |
| With normal glucose baseline | 1225 | 40.34%(1225/3037) |
| With HIV | 96 | 3.16%(96/3037) |
| With cirrhosis | 490 | 17.14%(490/2859) |
| With retreatment | 105 | 23.23%(105/452) |
| With DM treatment | 12 | 0.47%(12/2542) |
| ALT (means 97.3U/L) | 2780 | 91.54%(2780/3037) |
| IFN-alpha −2b/2a+RBV treatment | 604 | 25.55%(604/2364) |
| IFN-alpha −2b/2a alone | 216 | 9.14%(216/2364) |
| PEG IFN-alpha −2b/2a+RBV | 1441 | 60.96%(1441/2364) |
BMI: body mass index; HIV: human immunodeficiency virus; DM: diabetes mellitus; ALT: alanine aminotransferase; IFN: interferon; RBV: ribavirin.